Pharmaceuticals by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Takeda Pharmaceutical has the lowest figure of the 61 pharmaceuticals ranked by short interest, at 0.10%, followed by AstraZeneca (0.20%) and Novartis (0.24%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Takeda Pharmaceutical0.10%
- Median
- 5.47%
- Combined market value
- PLN 20.45T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Takeda PharmaceuticalTAK · Health Care | 0.10% | PLN 274.6B | PLN 85.96 | 1.29% down | 54% up | ||
| 2 | AstraZenecaAZN · Health Care | 0.20% | PLN 1.12T | PLN 719.15 | 1.96% down | 2% up | ||
| 3 | NovartisNVS · Health Care | 0.24% | PLN 1.19T | PLN 628.30 | 1.89% down | 25% up | ||
| 4 | SanofiSNY · Health Care | 0.51% | PLN 457B | PLN 190.34 | 0.49% down | 4% down | ||
| 5 | Johnson & JohnsonJNJ · Health Care | 0.71% | PLN 2.67T | PLN 1,107.29 | 1.28% down | 38% up | ||
| 6 | GSKGSK · Health Care | 0.81% | PLN 393.4B | PLN 196.27 | 0.95% down | 6% up | ||
| 7 | Eli LillyLLY · Health Care | 0.81% | PLN 4.98T | PLN 5,585.33 | 1.96% down | 35% up | ||
| 8 | Novo NordiskNVO · Health Care | 0.87% | PLN 703.5B | PLN 159.61 | 2.56% down | 17% down | ||
| 9 | GrifolsGRFS · Health Care | 0.88% | PLN 23.4B | PLN 34.35 | 1.10% down | 1% up | ||
| 10 | AbbVieABBV · Health Care | 0.89% | PLN 2.05T | PLN 1,159.89 | 1.57% down | 26% up | ||
| 11 | Merck & CoMRK · Health Care | 1.08% | PLN 1.38T | PLN 561.35 | 2.71% down | 51% up | ||
| 12 | Abbott LaboratoriesABT · Health Care | 1.10% | PLN 726.1B | PLN 419.23 | 0.52% down | 17% down | ||
| 13 | BeOne MedicinesONC · Health Care | 1.40% | PLN 185.5B | PLN 1,624.03 | 2.35% down | 17% up | ||
| 14 | GenmabGMAB · Health Care | 1.57% | PLN 127.4B | PLN 206.58 | 1.21% down | 70% up | ||
| 15 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | PLN 544.4B | PLN 2,147.33 | 0.12% down | 27% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | PLN 397.3B | PLN 3,840.69 | 0.36% down | 36% up | ||
| 17 | Royalty PharmaRPRX · Health Care | 2.27% | PLN 158.4B | PLN 275.43 | 0.35% down | 78% up | ||
| 18 | Bristol-Myers SquibbBMY · Health Care | 2.29% | PLN 493.3B | PLN 241.31 | 2.27% down | 34% up | ||
| 19 | PfizerPFE · Health Care | 2.36% | PLN 645.7B | PLN 113.29 | 1.12% down | 14% up | ||
| 20 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | PLN 198.5B | PLN 170.13 | 0.81% down | 74% up | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | PLN 50.2B | PLN 60.27 | 1.25% up | 5% up | ||
| 22 | ViatrisVTRS · Health Care | 3.07% | PLN 95.3B | PLN 83.13 | 1.00% up | 96% up | ||
| 23 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | PLN 30.2B | PLN 86.65 | 1.94% up | 83% up | ||
| 24 | Belite BioBLTE · Health Care | 3.40% | PLN 26B | PLN 640.53 | 0.91% up | 31% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | PLN 82.4B | PLN 615.26 | 2.31% down | 66% down | ||
| 26 | ZoetisZTS · Health Care | 4.12% | PLN 136.9B | PLN 337.03 | 0.32% up | 29% down | ||
| 27 | United TherapeuticsUTHR · Health Care | 4.31% | PLN 98.4B | PLN 2,310.36 | 1.72% down | 23% up | ||
| 28 | Ascendis PharmaASND · Health Care | 4.57% | PLN 71.2B | PLN 1,085.59 | 0.53% down | 28% up | ||
| 29 | ABIVAXABVX · Health Care | 4.70% | PLN 29.4B | PLN 336.32 | 1.79% up | 27% down | ||
| 30 | Summit TherapeuticsSMMT · Health Care | 5.28% | PLN 34.5B | PLN 43.08 | 0.33% up | 36% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | PLN 30.4B | PLN 386.75 | 1.04% up | 126% up | ||
| 32 | Legend BiotechLEGN · Health Care | 6.13% | PLN 12.7B | PLN 65.36 | 0.81% up | 42% down | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | 6.20% | PLN 28.2B | PLN 537.06 | 1.84% down | 7% down | ||
| 34 | Roivant SciencesROIV · Health Care | 6.28% | PLN 113B | PLN 155.95 | 0.10% up | 90% up | ||
| 35 | InsmedINSM · Health Care | 6.42% | PLN 106B | PLN 482.95 | 1.52% down | 40% down | ||
| 36 | Elanco Animal HealthELAN · Health Care | 6.59% | PLN 53B | PLN 106.12 | 2.01% up | 20% up | ||
| 37 | Definium TherapeuticsDFTX · Health Care | 7.02% | PLN 15.7B | PLN 114.64 | 3.05% down | 169% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | PLN 46.7B | PLN 241.02 | 2.36% up | 11% up | ||
| 39 | VeradermicsMANE · Health Care | 8.03% | PLN 21.1B | PLN 500.88 | 0.94% down | 233% up | ||
| 40 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | PLN 24.6B | PLN 174.26 | 0.72% up | 10% up | ||
| 41 | Corcept TherapeuticsCORT · Health Care | 8.34% | PLN 30.1B | PLN 274.71 | 2.58% down | 8% down | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | PLN 62.9B | PLN 980.05 | 1.17% up | 37% up | ||
| 43 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | PLN 38.3B | PLN 1,649.18 | 2.89% down | 24% down | ||
| 44 | PTC TherapeuticsPTCT · Health Care | 9.31% | PLN 20.3B | PLN 242.75 | 0.07% down | 20% down | ||
| 45 | Oruka TherapeuticsORKA · Health Care | 9.53% | PLN 26.4B | PLN 388.56 | 0.24% up | 241% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | 9.96% | PLN 19.4B | PLN 202.27 | 1.64% down | 44% up | ||
| 47 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | PLN 23.9B | PLN 366.55 | 0.95% down | 31% up | ||
| 48 | Cogent BiosciencesCOGT · Health Care | 10.0% | PLN 19.9B | PLN 114.09 | 1.80% up | 20% down | ||
| 49 | ErascaERAS · Health Care | 10.6% | PLN 18.7B | PLN 53.20 | 4.82% down | 403% up | ||
| 50 | BridgeBio PharmaBBIO · Health Care | 10.7% | PLN 60.8B | PLN 312.26 | 1.03% up | 17% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | PLN 18B | PLN 164.36 | 2.85% down | 88% up | ||
| 52 | AlkermesALKS · Health Care | 11.7% | PLN 31.5B | PLN 187.56 | 2.54% up | 58% up | ||
| 53 | Spyre TherapeuticsSYRE · Health Care | 12.2% | PLN 36.4B | PLN 383.09 | 1.47% up | 286% up | ||
| 54 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | PLN 24.1B | PLN 1,204.84 | 1.90% up | 43% up | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | PLN 18.3B | PLN 109.97 | 1.35% up | 64% down | ||
| 56 | CytokineticsCYTK · Health Care | 12.9% | PLN 28.7B | PLN 205.89 | 0.95% down | 20% down | ||
| 57 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | PLN 34.3B | PLN 1,226.21 | 0.12% down | 61% up | ||
| 58 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | PLN 32.7B | PLN 501.25 | 0.10% down | 46% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | PLN 19.6B | PLN 347.63 | 0.69% down | 113% up | ||
| 60 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | PLN 32.6B | PLN 469.65 | 0.08% up | 13% up | ||
| 61 | TG TherapeuticsTGTX · Health Care | 19.0% | PLN 39.3B | PLN 259.76 | 2.93% up | 107% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0244 PLN).
Questions and answers
Which pharmaceuticals have the lowest short interest?
Takeda Pharmaceutical (0.10%), AstraZeneca (0.20%) and Novartis (0.24%) have the lowest short interest of the 61 pharmaceuticals ranked here as of the 30 Oct 2026 settlement date.
How many pharmaceuticals are in this ranking?
61 are ranked by short interest.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by short interest have a combined market value of PLN 20.45T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceuticals by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.